• The Swiss health regulatory agency, Swissmedic, authorizes the use of the vaccine developed by the Pfizer/BioNTech duo against COVID-19 after a risk-benefit assessment. The European Medicines Agency (EMA) is meeting today to review the vaccine and report its findings.
  • Apple is temporarily closing its 53 stores in California due to the pandemic.
  • The Federal Reserve said it would allow share buyback and dividend payment again for banks, provided that their total amount does not exceed the average net income of the previous four quarters.
  • The European Commission has cleared the proposed merger between Fiat Chrysler Automobiles and PSA. The clearance is conditional upon full compliance with a series of commitments offered by both companies.
  • Lockheed Martin acquired U.S. rocket manufacturer Aerojet Rocketdyne Holdings for $4.4 billion.
  • Tesla enters the S&P500.
  • Health Canada expects the approval process for the vaccine developed by Moderna to take a few weeks, but is unable to give a specific date.
  • Canadian cannabis producer Hexo announces the consolidation of its shares, from four old shares to one new share.
  • Royal Dutch Shell sells a $2.5 billion stake in a division owning Australian liquefied natural gas export infrastructure.
  • Roche records positive results in the treatment of diabetic macular edema.
  • Lonza acquires new infrastructure in Visp.